Analysts have clear opinions on SILK.
There are 1 analyst offering 12 month price targets for Silk Road Medical in the last 3 months. The average price target is $51.00 with a high forecast of $51.00 and a low forecast of $51.00. The average price target represents a 120.21% increase from the last price of $23.16.
Silk Road Medical, Inc (SILK) is followed by 1 analysts on the street.
null from rates it a .
Similarly, null of a with a target of .
The consensus on the street is null.
What does Silk Road Medical, Inc(SILK) do ?
Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm’s devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional approach of accessing the vascular system through the groin. Its products include ENROUTE Transcarotid Neuroprotection & Stent System. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.
Silk Road Medical, Inc (SILK) Insider Trades
Multiple company employees have indulged in significant insider trading. Silk Road Medical, Inc disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):
CFO, Buchanan Lucas W. : S – Sale+OE(-$3,025) of SILK in the trading session of 2020-03-16.
Pres, CEO Rogers Erica J. : S – Sale+OE(-$748,942) of SILK in the trading session of 2020-03-11.
EVPGlobal Sales, amp; Marketin Davis Andrew S. : S – Sale+OE(-$267,590) of Silk Road Medical, Inc in the trading session of 2020-03-02.